{"organizations": [], "uuid": "b7d080e1031098317103b6b964776b6d54a3352e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "http://si.wsj.net/img/WSJ_Logo_black_social.gif", "site_section": "http://www.wsj.com/news/markets", "section_title": "Stock Market &amp; Finance News - Wall Street Journal", "url": "http://www.wsj.com/articles/novocure-shares-tumble-in-market-debut-1443798658", "country": "", "title": "NovoCure Shares Tumble in Market Debut", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "NovoCure Shares Tumble in Market Debut - WSJ", "spam_score": 0.0, "site_type": "news", "published": "2015-10-02T21:31:00.000+03:00", "replies_count": 0, "uuid": "b7d080e1031098317103b6b964776b6d54a3352e"}, "author": "Lisa Beilfuss", "url": "http://www.wsj.com/articles/novocure-shares-tumble-in-market-debut-1443798658", "ord_in_thread": 0, "title": "NovoCure Shares Tumble in Market Debut", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Shares in oncology company NovoCure Ltd. tumbled in their trading debut Friday, the latest example of investorsâ€™ waning appetite for biotechnology shares and for initial public offerings.\nNovoCure shares opened at $20.16, below their initial public offering price of $22 and valuing the company around $1.67 billion. The company initially hoped to offer shares at $26 to $29 a piece but had cut that guidance to $23 to $24 amid growing... To Read the Full Story, Subscribe or Sign In", "external_links": [], "published": "2015-10-02T21:31:00.000+03:00", "crawled": "2015-10-02T20:45:44.851+03:00", "highlightTitle": ""}